Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02875730Phase 4Completed

A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement

Role: lead

NCT00976053Phase 4Completed

Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging

Role: lead

NCT01373944Completed

Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI

Role: lead

All 3 trials loaded